Archives
-
RP3-340N1.2, IL-6, and NSCLC Progression
2026-08-31
This study identifies the lncRNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 mRNA stability in non-small cell lung cancer. Its knockdown enhances ZC3H12A-associated IL-6 mRNA degradation, reduces tumor-cell proliferation and migration, and weakens tumor-promoting communication involving macrophages.
-
Trypsin-Responsive Nanomedicine for Acute Pancreatitis
2026-08-30
Wang and colleagues developed a mesenchymal-stem-cell-membrane-coated mesoporous organosilica nanoparticle that targets injured pancreatic acinar cells and releases BAPTA-AM after trypsin-mediated scaffold cleavage. In a mouse model, this design reduced intracellular calcium overload, suppressed inflammatory and necrotic signaling, improved pancreatic biomarkers, and increased survival, while also illustrating how disease-specific enzymatic activation can improve precision drug delivery.
-
2'-O-Methyladenosine in Purine Assays
2026-08-29
Use 2'-O-Methyladenosine as both a defined nucleoside input for cell experiments and an analytical standard for sensitive purine metabolomics. A matrix-aware UHPLC–MS/MS workflow adds practical advantages for RNA modification nucleosides, transport studies, and nucleoside analog research.
-
JSH-23: Mechanism of an NF-κB Inhibitor
2026-08-28
JSH-23 is a small-molecule NF-κB inhibitor that blocks p65 nuclear localization and DNA binding without preventing IκB degradation. Its reported activity in LPS-stimulated macrophages and a cisplatin-induced acute kidney injury model supports its use in inflammation research and NF-κB signaling pathway study.
-
HMGCS2, LysoPC, and Pulmonary Fibrosis
2026-08-28
Yang et al. identify injured type II alveolar epithelial cells as a major source of LysoPC accumulation in bleomycin-induced pulmonary fibrosis and show that these lipids activate lung fibroblasts. The study connects epithelial HMGCS2 loss with impaired lipid degradation through the PPARα–CPT1A/CPT2 axis, offering a mechanistic framework for lipid-focused fibrosis research.
-
TNF-alpha Recombinant Murine Protein: Workflows
2026-08-27
Build reproducible apoptosis and inflammation assays with a trimeric, highly active murine cytokine and a practical dosing workflow. Pair TNF-driven receptor signaling with modern transcription-independent death assays to distinguish stimulus-specific mechanisms from general loss of viability.
-
Rotavirus Infection, Nrf2 Loss, and Redox Defense
2026-08-27
The reference study shows that rotavirus infection produces a biphasic Nrf2 response: an early stress-associated increase is followed by progressive Nrf2 depletion, nuclear loss, and suppression of antioxidant transcription. Its combination of temporal infection analysis, redox perturbation, turnover-pathway testing, and ubiquitination evidence suggests that late Nrf2 failure is not simply a consequence of oxidative stress, providing a useful framework for oxidative stress research and antiviral cell biology.
-
Malate as a Causal Probe of Mitochondrial Redox
2026-08-26
Malate is more than a tricarboxylic acid cycle intermediate: it is a controllable probe of mitochondrial redox, carbon flux, and tumor–immune signaling. This article explains how to use malate to interpret PDHA1-driven metabolic changes without confusing upstream flux effects with direct α-ketoglutarate signaling.
-
Quizartinib (AC220) Workflows for FLT3 Research
2026-08-26
Quizartinib (AC220) combines low-nanomolar FLT3 potency with selectivity that supports clean pathway-dissection experiments in AML models. This practical guide translates its biochemical, cellular, and xenograft utility into reproducible workflows while showing how recent FLT3 resistance research can inform assay design.
-
From BATF2–ATF3 to Actionable Protein Interactomes
2026-08-25
The BATF2–ATF3 axis offers a mechanistic entry point into intervertebral disc degeneration, but translational progress depends on validating the protein complexes behind the phenotype. This article outlines how magnetic co-immunoprecipitation can connect disease biology with reproducible interaction analysis, while defining controls, limitations, and strategic next steps.
-
5-Aminolevulinic acid HCl: Heme Pathway Workflows
2026-08-25
Use 5-Aminolevulinic acid HCl as a controllable entry point for studying bacterial heme metabolism, macrophage uptake, and porphyrin-associated fluorescence. This workflow translates a Salmonella virulence finding into practical dose-response, rescue, and imaging assays while clearly separating validated evidence from experimental extensions.
-
Pentoxifylline Workflows for Inflammation Research
2026-08-24
Pentoxifylline connects cAMP elevation with measurable changes in monocyte activation, ICAM-1 expression, and cytokine signaling. This guide turns the reference findings into practical cell-based workflows, mechanistic controls, translational model choices, and troubleshooting checkpoints.
-
EHEC and Danazol Models of Precocious Puberty
2026-08-24
The reference study evaluated an Eclipta prostrata–Hordeum vulgare extract complex in rat models of precocious puberty induced by Danazol or a high-fat diet. EHEC delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH expression without changing body weight, supporting further investigation of HPG-axis modulation while leaving important translational questions unresolved.
-
20-HETE–TRPV1 Signaling in Chronic Dermatitis Itch
2026-08-23
Yu and colleagues show that elevated 20-HETE activates sensitized TRPV1 channels on MrgprA3+ sensory neurons, converting normally painful chemical input into itch and pain in chronic dermatitis. The study combines behavioral, chemogenetic, electrophysiological, metabolomic, and pharmacological evidence to identify the 20-HETE–TRPV1–MrgprA3+ axis as a peripheral mechanism of sensory switching.
-
TBST Workflows for uPAR–uPA Assay Optimization
2026-08-22
TBST provides a practical way to control background during Western blotting, immunofluorescence, immunohistochemistry, and related antibody assays used to study uPAR–uPA biology. This guide translates findings from a breast-cancer metastasis study into reproducible buffer choices, workflow parameters, and troubleshooting strategies without confusing assay support with therapeutic efficacy.